US5693769A
(en)
*
|
1991-12-13 |
1997-12-02 |
Transcell Technologies, Inc. |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
US5795870A
(en)
*
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
US6235888B1
(en)
|
1994-10-05 |
2001-05-22 |
The General Hospital Corporation |
Hepatitis C virus vaccine
|
US5703057A
(en)
*
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
US6326007B1
(en)
*
|
1995-07-20 |
2001-12-04 |
The Regents Of The University Of California |
Attenuated lentivirus vectors expressing interferon
|
SE9602280D0
(sv)
*
|
1996-06-10 |
1996-06-10 |
Pharmatrix Ab |
Immunstimulerande lipidformulering
|
WO1998000554A1
(en)
|
1996-07-03 |
1998-01-08 |
Genetics Institute, Inc. |
Protease fmh-1, an ice/ced-like protease
|
US20070213290A1
(en)
*
|
1996-10-17 |
2007-09-13 |
Kingsman Alan J |
Neurite regeneration
|
US7198784B2
(en)
*
|
1996-10-17 |
2007-04-03 |
Oxford Biomedica (Uk) Limited |
Retroviral vectors
|
ATE429929T1
(de)
|
1996-10-23 |
2009-05-15 |
Univ Pennsylvania |
Verbesserte impfstoffe
|
US6146847A
(en)
*
|
1996-11-01 |
2000-11-14 |
Genespan Corporation |
Stabilized transient gene expression
|
CN1238807A
(zh)
*
|
1996-11-01 |
1999-12-15 |
基因观测公司 |
稳定的瞬时基因表达
|
US20060002949A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
US20060002959A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Government Of The United States |
Skin-sctive adjuvants for transcutaneous immuization
|
US5980898A
(en)
*
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
GB9626539D0
(en)
*
|
1996-12-20 |
1997-02-05 |
Univ Liverpool |
A method of enhancing the rate of transfection of cells
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
EP1017283B1
(en)
*
|
1997-02-14 |
2004-12-15 |
Merck & Co., Inc. |
Polynucleotide vaccine formulations
|
US20040242522A1
(en)
*
|
1997-02-14 |
2004-12-02 |
Volkin David B. |
Polynucleotide vaccine formulations
|
WO1998046263A1
(en)
*
|
1997-04-14 |
1998-10-22 |
University Of Massachusetts Medical Center |
Saponin adjuvants in combination with dna vaccination
|
FR2763958A1
(fr)
*
|
1997-05-29 |
1998-12-04 |
Transgene Sa |
Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique
|
AU707186B2
(en)
*
|
1997-07-01 |
1999-07-01 |
Transgene S.A. |
Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6348450B1
(en)
*
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
US6818627B1
(en)
|
1997-08-14 |
2004-11-16 |
The Trustees Of The University Of Pennsylvania |
Functional fragments of HIV-1 Vpr protein and methods of using the same
|
US20040258703A1
(en)
*
|
1997-11-14 |
2004-12-23 |
The Government Of The Us, As Represented By The Secretary Of The Army |
Skin-active adjuvants for transcutaneous immunization
|
US6355244B1
(en)
*
|
1997-11-17 |
2002-03-12 |
University Of Kentucky Research Foundation |
Methods and compositions for the treatment of psoriasis
|
KR100735651B1
(ko)
|
1997-11-28 |
2007-07-06 |
세로노 제네틱스 인스티튜트 에스.에이. |
클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
|
US5994136A
(en)
*
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
US7078500B1
(en)
|
1998-01-30 |
2006-07-18 |
The General Hospital Corporation |
Genetic immunization with nonstructural proteins of hepatitis C virus
|
IL138075A0
(en)
|
1998-02-27 |
2001-10-31 |
Univ Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
EP0967289A1
(en)
*
|
1998-05-06 |
1999-12-29 |
Transgene S.A. |
Improvements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor
|
WO1999056784A2
(en)
*
|
1998-05-06 |
1999-11-11 |
Transgene S.A. |
Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
|
US6797512B1
(en)
|
1998-11-13 |
2004-09-28 |
Cell Genesys, Inc. |
Selection system for generating efficient packaging cells for lentiviral vectors
|
ATE366740T1
(de)
*
|
1998-11-13 |
2007-08-15 |
Cell Genesys Inc |
Auswahlverfahren zur erzeugung effizienter pack- zellen für lentivirale vektoren
|
EP1168918A4
(en)
|
1999-03-03 |
2002-08-21 |
Univ Pennsylvania |
VACCINE AND GENE THERAPY COMPOSITIONS AND METHOD FOR THEIR PRODUCTION AND USE
|
AU4188100A
(en)
*
|
1999-04-08 |
2000-11-14 |
Gregory M. Glenn |
Dry formulation for transcutaneous immunization
|
WO2000063364A2
(en)
|
1999-04-21 |
2000-10-26 |
American Home Products Corporation |
Methods and compositions for inhibiting the function of polynucleotide sequences
|
WO2000066759A1
(en)
|
1999-04-29 |
2000-11-09 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
JP2002542800A
(ja)
|
1999-04-30 |
2002-12-17 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア |
変異体ヒトcd80および組成物およびその作製および使用法
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
CA2371095A1
(en)
*
|
1999-05-05 |
2000-11-16 |
Michela Seveso |
Enhanced delivery of nucleic acid-based drugs
|
US6565528B1
(en)
|
1999-05-07 |
2003-05-20 |
Scimed Life Systems, Inc. |
Apparatus and method for delivering therapeutic and diagnostic agents
|
EP1187652B1
(en)
*
|
1999-06-02 |
2006-10-11 |
Boston Scientific Limited |
Devices for delivering a drug
|
US7147633B2
(en)
*
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
EP1188835A4
(en)
*
|
1999-06-22 |
2004-07-07 |
Dnavec Research Inc |
A VECTOR FOR THE EXPRESSION OF TWO FOREIGN GENES
|
CN1379819A
(zh)
*
|
1999-06-28 |
2002-11-13 |
俄克拉荷马州医学研究基金会 |
具有催化活性的重组memapsin蛋白酶及其应用方法
|
US6319224B1
(en)
*
|
1999-08-20 |
2001-11-20 |
Bioject Medical Technologies Inc. |
Intradermal injection system for injecting DNA-based injectables into humans
|
ATE374622T1
(de)
*
|
1999-11-03 |
2007-10-15 |
Powderject Vaccines Inc |
Genetische impstoffe mit adjuvans
|
US6279656B1
(en)
|
1999-11-03 |
2001-08-28 |
Santrol, Inc. |
Downhole chemical delivery system for oil and gas wells
|
DK1230268T3
(da)
|
1999-11-18 |
2010-02-08 |
Epimmune Inc |
Heteroklitiske analoger af klasse I-epitoper
|
KR100863823B1
(ko)
*
|
1999-12-22 |
2008-10-15 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
코스미드 dna 작제물 및 이를 제조하고 이용하는 방법
|
AU2001259291B2
(en)
*
|
2000-04-28 |
2006-11-23 |
Aventis Pasteur Limited |
Improved immunogenicity using a combination of DNA and vaccinia virus vector vaccines
|
EP1292285A4
(en)
*
|
2000-06-02 |
2009-07-22 |
Eisai Corp North America |
SYSTEMS FOR DISPENSING BIOACTIVE AGENTS
|
EP1299727B1
(en)
|
2000-07-12 |
2009-04-22 |
Agensys, Inc. |
Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
|
DE60134408D1
(de)
*
|
2000-07-14 |
2008-07-24 |
Univ Pennsylvania |
Für akzessorische hiv proteine kodierende dna impfstoffe
|
WO2002010410A1
(en)
*
|
2000-07-27 |
2002-02-07 |
The Trustees Of The University Of Pennsylvania |
Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
|
US6680059B2
(en)
*
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
*
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
US6858590B2
(en)
*
|
2000-08-17 |
2005-02-22 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
EP2022797A3
(en)
|
2000-08-28 |
2011-11-09 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
|
JP2004510714A
(ja)
|
2000-10-04 |
2004-04-08 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア |
フラビウイルス及びペスチウイルス由来のキャプシド蛋白質を使用する組成物及び方法
|
AU2001298049A1
(en)
|
2000-10-19 |
2003-05-19 |
Epimmune Inc. |
Hla class i and ii binding peptides and their uses
|
US7122180B2
(en)
*
|
2000-10-23 |
2006-10-17 |
Children's Medical Center Corporation |
DNA vectors containing mutated HIV proviruses
|
ATE398461T1
(de)
*
|
2001-02-13 |
2008-07-15 |
Us Gov Sec Army |
Impstoffe zur transkutanen immunisierung gegen reisediarrhö
|
US6924358B2
(en)
|
2001-03-05 |
2005-08-02 |
Agensys, Inc. |
121P1F1: a tissue specific protein highly expressed in various cancers
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
AU2002258603A1
(en)
*
|
2001-03-23 |
2002-10-15 |
University Of Michigan |
Method of inhibiting cancerous cell proliferation using ras mutants of gdp-bound conformation
|
US20040028651A1
(en)
*
|
2001-03-29 |
2004-02-12 |
Karrupiah Muthumani |
Composition and methods of using hiv vpr
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
CA2443123A1
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US8058248B2
(en)
*
|
2001-04-26 |
2011-11-15 |
The United States Of America As Represented By The Secretary Of Agriculture |
Foot and mouth disease virus vaccine comprising interferons
|
DE60233047D1
(de)
*
|
2001-05-14 |
2009-09-03 |
Gbp Ip Llc |
Lentivirale vektoren kodierend für gerinnungsfaktoren für die gentherapie
|
JP2005505271A
(ja)
|
2001-09-06 |
2005-02-24 |
アジェンシス, インコーポレイテッド |
癌の処置および検出において有用なsteap−1と名称が与えられる核酸および対応するタンパク質
|
AR045702A1
(es)
*
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
CN1564696A
(zh)
*
|
2001-10-05 |
2005-01-12 |
宾西法尼亚大学托管人 |
治疗和预防全身炎性反应综合症/败血症的药物组成和方法
|
MX339524B
(es)
*
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
JP2005532789A
(ja)
|
2002-03-15 |
2005-11-04 |
ワイス・ホールデイングス・コーポレーシヨン |
減少した酵素活性を有する型別不能なインフルエンザ菌(Haemophilusinfluenza)のP4タンパク質の変異体
|
US6485711B1
(en)
|
2002-03-21 |
2002-11-26 |
Michael J. Olmstead |
Organic toothpaste containing saponin
|
US20040180438A1
(en)
*
|
2002-04-26 |
2004-09-16 |
Pachuk Catherine J. |
Methods and compositions for silencing genes without inducing toxicity
|
WO2004041997A2
(en)
*
|
2002-05-01 |
2004-05-21 |
National Institutes Of Health |
Immunotherapy regimens in hiv-infected patients
|
AU2003266014B2
(en)
*
|
2002-05-06 |
2009-05-14 |
Alnylam Pharmaceuticals, Inc. |
Methods for delivery of nucleic acids
|
AU2003221581A1
(en)
*
|
2002-05-06 |
2003-11-17 |
University Of British Columbia |
Expression system for large functional proteins
|
CA2385110A1
(en)
*
|
2002-05-06 |
2003-11-06 |
University Of British Columbia |
Co-expression system for large functional proteins
|
EP1521523A4
(en)
*
|
2002-05-20 |
2006-04-19 |
Univ Texas |
METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACID ENZYMES AND MOLECULES IN BRAIN, BONE, AND OTHER FABRICS
|
US7563882B2
(en)
|
2002-06-10 |
2009-07-21 |
University Of Rochester |
Polynucleotides encoding antibodies that bind to the C35 polypeptide
|
AU2003243663A1
(en)
*
|
2002-06-20 |
2004-01-06 |
The Trustees Of The University Of Pennsylvania |
Vaccines for suppressing ige-mediated allergic disease and methods for using the same
|
AU2003274906A1
(en)
*
|
2002-07-31 |
2004-02-16 |
Nucleonics, Inc. |
Double stranded rna structures and constructs, and methods for generating and using the same
|
WO2004016733A2
(en)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
WO2004028442A2
(en)
*
|
2002-09-26 |
2004-04-08 |
Pfizer Products Inc. |
Use of excipients to increase dna uptake by swine muscle cells
|
CA2506695A1
(en)
*
|
2002-11-19 |
2004-06-03 |
The Trustees Of The University Of Pennsylvania |
Genetic constructs and compositions comprising rre and cte and uses thereof
|
CA2503346C
(en)
|
2002-11-27 |
2014-03-18 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
|
EP1903056A3
(en)
|
2002-12-10 |
2008-05-07 |
Idm Pharma, Inc. |
HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof
|
CA2511927A1
(en)
*
|
2002-12-27 |
2004-08-12 |
Shenzhen Tsinghua Yuanxing Bio-Pharm Science & Technology Co., Ltd. |
Method of preparing a vaccine and anti-tumor vaccines
|
CA2860151A1
(en)
|
2003-02-10 |
2004-08-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
|
EP1618185A4
(en)
*
|
2003-04-16 |
2009-05-27 |
Wyeth Corp |
NEW IMMUNOLOGICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCOULAR DISEASE
|
WO2004105681A2
(en)
*
|
2003-04-28 |
2004-12-09 |
Innogenetics N.V. |
Cd4+ human papillomavirus (hpv) epitopes
|
US20070073048A1
(en)
*
|
2003-05-15 |
2007-03-29 |
Ying Lian |
Hiv polynucleotides and polypeptides derived from botswana mj4
|
CN101090729B
(zh)
|
2003-05-30 |
2014-07-23 |
艾更斯司股份有限公司 |
前列腺干细胞抗原(psca)变体及其序列
|
JP4980716B2
(ja)
|
2003-06-12 |
2012-07-18 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
遺伝子サイレンシングに有用な保存されたhbv及びhcv配列
|
NZ570709A
(en)
*
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
WO2004112706A2
(en)
|
2003-06-13 |
2004-12-29 |
The Trustees Of The University Of Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
US20050106159A1
(en)
*
|
2003-08-12 |
2005-05-19 |
Thompson Stuart A. |
Campylobacter jejuni outer membrane protein immunogenic composition
|
EP1656453A2
(en)
*
|
2003-08-22 |
2006-05-17 |
Nucleonics, Inc. |
Eukaryotic expression systems for expression of inhibitory rna in multiple intracellular compartments
|
JP4647606B2
(ja)
*
|
2003-09-05 |
2011-03-09 |
ジェネンコー・インターナショナル・インク |
Hpvcd8+t細胞エピトープ
|
EP1697399B1
(en)
|
2003-12-12 |
2016-11-23 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS |
A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
|
US20060205070A1
(en)
*
|
2004-01-13 |
2006-09-14 |
The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
HIV TEV compositions and methods of use
|
WO2005086637A2
(en)
*
|
2004-02-11 |
2005-09-22 |
Ligocyte Pharmaceuticals, Inc. |
Anthrax antigens and methods of use
|
US20050261210A1
(en)
*
|
2004-02-19 |
2005-11-24 |
Bhatnagar Rajiv S |
Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
|
US20080160040A1
(en)
*
|
2004-04-15 |
2008-07-03 |
Ghim Shin-Je |
Plant-produced compositions for treating papillomavirus infection and related methods
|
AU2005250370B2
(en)
|
2004-05-28 |
2010-04-01 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
TW200613554A
(en)
|
2004-06-17 |
2006-05-01 |
Wyeth Corp |
Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
|
US8992999B2
(en)
*
|
2004-06-25 |
2015-03-31 |
Alltech, Inc. |
Methods and compositions for controlling parasitic infections of animals
|
JP4804467B2
(ja)
|
2004-08-23 |
2011-11-02 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
多重rnaポリメラーゼiiiプロモーター発現構築物
|
EP1797185B1
(en)
|
2004-09-24 |
2011-04-13 |
Alnylam Pharmaceuticals, Inc. |
Targeting opposite strand replication intermediates of single-stranded viruses by rnai
|
DE602005027747D1
(de)
|
2004-12-22 |
2011-06-09 |
Alnylam Pharmaceuticals Inc |
Zum gen-silencing geeignete konservierte hbv- und hcv-sequenzen
|
AU2006212885A1
(en)
*
|
2005-02-11 |
2006-08-17 |
Merck & Co., Inc. |
Adenovirus serotype 26 vectors, nucleic acid and viruses produced thereby
|
WO2006091722A2
(en)
*
|
2005-02-23 |
2006-08-31 |
Uab Research Foundation |
Alkyl-glycoside enhanced vaccination
|
DK2325306T3
(en)
|
2005-02-25 |
2014-03-03 |
Oncotherapy Science Inc |
Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
|
WO2006093030A1
(en)
|
2005-02-28 |
2006-09-08 |
Oncotherapy Science, Inc. |
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
|
WO2006105488A2
(en)
|
2005-03-31 |
2006-10-05 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161p2f10b proteins
|
EP1888751A2
(en)
*
|
2005-05-25 |
2008-02-20 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
CA2616497C
(en)
|
2005-07-27 |
2016-06-07 |
Oncotherapy Science, Inc. |
Colon cancer related gene tom34
|
WO2007021886A2
(en)
*
|
2005-08-10 |
2007-02-22 |
Oklahoma Medical Research Foundation |
Truncated memapsin 2 for use for treating alzheimer's disease
|
EP1934335A4
(en)
*
|
2005-09-08 |
2010-05-05 |
Large Scale Biology Corp |
MODIFIED TOBACCO MOSAIC VIRUS PARTICLES AS MEDIA FOR THE DISPOSAL OF PROTEIN ANTIGENS FOR VACCINE APPLICATIONS
|
KR101421745B1
(ko)
|
2006-01-13 |
2014-07-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
코돈 최적화된 il―15를 사용하는 백신 및 면역치료제, 및 그의 사용 방법
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
WO2007109583A2
(en)
|
2006-03-17 |
2007-09-27 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
|
CN105063064A
(zh)
|
2006-07-28 |
2015-11-18 |
宾夕法尼亚大学托管会 |
改进的疫苗及其使用方法
|
KR101454287B1
(ko)
|
2006-10-17 |
2014-11-04 |
온코세라피 사이언스 가부시키가이샤 |
Mphosph1 또는 depdc1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
|
WO2008079818A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Soluprin Pharmaceuticals, Inc. |
Intravenous administration of water soluble analgesic formulations
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
TWI438207B
(zh)
|
2007-02-21 |
2014-05-21 |
Oncotherapy Science Inc |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
TW201425333A
(zh)
|
2007-04-11 |
2014-07-01 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌8胜肽及包含此胜肽之疫苗
|
EP2185195A2
(en)
*
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Immunogen platform
|
US20090214593A1
(en)
*
|
2007-08-16 |
2009-08-27 |
Tripep Ab |
Immunogen platform
|
EP2612868B1
(en)
|
2007-11-01 |
2018-08-15 |
Astellas Pharma Inc. |
Immunosuppressive polypeptides and nucleic acids
|
US20100310640A1
(en)
*
|
2007-11-01 |
2010-12-09 |
Knutson Keith L |
Hla-dr binding peptides and their uses
|
EP2231880A4
(en)
*
|
2007-12-04 |
2011-09-14 |
Prionics Ag |
KIT AND METHOD FOR DETECTING BOVINE VIRAL DIARRHEA VIRUS IN TISSUE SAMPLES
|
US8852609B2
(en)
*
|
2008-04-04 |
2014-10-07 |
The Trustees Of The University Of Pennsylvania |
Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
|
CA2720168C
(en)
|
2008-04-04 |
2024-04-30 |
David B. Weiner |
Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
|
US7928189B2
(en)
*
|
2008-05-05 |
2011-04-19 |
Ottawa Health Research Institute |
PCSK9 polypeptide fragment
|
EP2853269B1
(en)
|
2008-05-19 |
2019-05-01 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens comprising a recombinant Listeria strain attenuated by mutation of dal/dat and deletion of ActA comprising a nucleic acid molecule encoding an listeriolysin O - prostate specific anigen fusion protein
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
JP5764822B2
(ja)
|
2008-08-27 |
2015-08-19 |
オンコセラピー・サイエンス株式会社 |
がんの治療および診断の標的遺伝子としてのprmt1
|
EP2352747A1
(en)
*
|
2008-10-23 |
2011-08-10 |
Intervet International BV |
Lawsonia intracellularis vaccines
|
WO2010050939A1
(en)
|
2008-10-29 |
2010-05-06 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
TWI500932B
(zh)
|
2008-12-05 |
2015-09-21 |
Oncotherapy Science Inc |
Wdrpuh抗原決定位胜肽以及含此胜肽之疫苗
|
CN102333863A
(zh)
|
2009-01-13 |
2012-01-25 |
干细胞生物科技公司 |
非胚胎干细胞及其用途
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
CA2653478A1
(en)
*
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Foxm1胜肽以及含此胜肽之疫苗
|
CN102356155B
(zh)
|
2009-03-18 |
2016-02-24 |
肿瘤疗法科学股份有限公司 |
Neil3肽及包含它的疫苗
|
US20120213744A1
(en)
|
2009-04-27 |
2012-08-23 |
Ottawa Hospital Research Institute |
Compositions and methods for modulating stem cells and uses thereof
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Cdc45l胜肽與含此胜肽之疫苗
|
KR20120093163A
(ko)
|
2009-09-14 |
2012-08-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Il-15 수용체 알파 및/또는 이를 인코딩하는 핵산 분자를 포함하는 백신 및 면역 치료제, 및 이를 이용하는 방법
|
KR102138780B1
(ko)
|
2009-11-02 |
2020-07-29 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
구제역 바이러스(fmdv) 공통 단백질, 이를 위한 코딩 서열 및 이로부터 만들어진 백신
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
KR101784177B1
(ko)
|
2010-02-08 |
2017-10-11 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Rantes를 암호화하는 핵산 분자, 그리고 이를 포함하는 조성물 및 이의 사용 방법
|
WO2011106705A2
(en)
|
2010-02-26 |
2011-09-01 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Dna-protein vaccination protocols
|
BR112012022641A2
(pt)
|
2010-03-11 |
2017-02-14 |
Oncotherapy Science Inc |
peptídeos hjurp e vacinas que incluem os mesmos
|
EP3187585A1
(en)
|
2010-03-25 |
2017-07-05 |
Oregon Health&Science University |
Cmv glycoproteins and recombinant vectors
|
TWI538685B
(zh)
|
2010-04-02 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ect2胜肽及含此胜肽之疫苗
|
TWI542691B
(zh)
|
2010-08-04 |
2016-07-21 |
幹細胞生物科技公司 |
體幹細胞
|
ES2850973T3
(es)
|
2010-08-23 |
2021-09-01 |
Wyeth Llc |
Formulaciones estables de antígenos rLP2086 de Neisseria meningitidis
|
WO2012032489A1
(en)
|
2010-09-10 |
2012-03-15 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
WO2012138377A2
(en)
|
2010-10-01 |
2012-10-11 |
Trustees Of The University Of Pennsylvania |
The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
|
AU2011325893B2
(en)
|
2010-11-12 |
2016-01-14 |
Inovio Pharmaceuticals, Inc |
Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same
|
WO2012071513A2
(en)
|
2010-11-24 |
2012-05-31 |
Hong Gao |
Expanding hematopoietic stem cells
|
JP6099573B2
(ja)
|
2011-01-31 |
2017-03-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
新規なヘルペス抗原をコードする核酸分子、それを含むワクチン及びその使用方法
|
PT2672992T
(pt)
|
2011-02-11 |
2020-07-27 |
Univ Pennsylvania |
Molécula de ácidos nucleicos codificando proteína nuclear do vírus da hepatite b e vacina compreendendo a mesma
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
WO2012125551A1
(en)
|
2011-03-11 |
2012-09-20 |
Advaxis |
Listeria-based adjuvants
|
DK2691530T3
(en)
|
2011-06-10 |
2018-05-22 |
Univ Oregon Health & Science |
CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
|
WO2013006834A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Oil-in-water emulsions that contain nucleic acids
|
JP6120839B2
(ja)
|
2011-07-06 |
2017-04-26 |
ノバルティス アーゲー |
カチオン性水中油型エマルジョン
|
CA2841852C
(en)
|
2011-07-11 |
2020-06-30 |
Inovio Pharmaceuticals, Inc. |
Cross-protective arenavirus vaccines and their method of use
|
EP2738255B1
(en)
|
2011-07-29 |
2016-11-23 |
Tokushima University |
Erap1-derived peptide and use thereof
|
KR102015648B1
(ko)
|
2011-08-12 |
2019-08-28 |
온코세라피 사이언스 가부시키가이샤 |
Mphosph1 펩티드 및 이를 포함한 백신
|
EP2568289A3
(en)
|
2011-09-12 |
2013-04-03 |
International AIDS Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
JP2014527818A
(ja)
|
2011-09-16 |
2014-10-23 |
フェイト セラピューティクス,インコーポレイテッド |
Wnt組成物およびそのような組成物の治療的使用
|
EP2751257B1
(en)
|
2011-09-16 |
2018-06-27 |
Ottawa Hospital Research Institute |
Wnt7a compositions and methods of using the same
|
TWI571513B
(zh)
|
2011-09-28 |
2017-02-21 |
幹細胞生物科技股份有限公司 |
體幹細胞及其製備方法
|
EP3443982A1
(en)
|
2011-10-12 |
2019-02-20 |
The Trustees of the University of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
KR101679731B1
(ko)
|
2011-10-24 |
2016-11-25 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 hcv 백신 및 이것을 사용하는 방법
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
CA2852633C
(en)
|
2011-10-28 |
2021-08-03 |
Oncotherapy Science, Inc. |
Topk peptides and vaccines including the same
|
US10206997B2
(en)
|
2011-11-10 |
2019-02-19 |
Bin Wang |
Facilitator-DNA combination vaccine
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
NZ628449A
(en)
|
2012-03-09 |
2016-04-29 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
CN104411327A
(zh)
|
2012-03-12 |
2015-03-11 |
阿德瓦希斯公司 |
李斯特菌疫苗治疗以后的抑制细胞功能抑制
|
CN104619719A
(zh)
|
2012-04-10 |
2015-05-13 |
宾夕法尼亚大学理事会 |
人呼吸道合胞病毒共有抗原、由其制备的核酸构建体和疫苗及其使用方法
|
EP2679596B1
(en)
|
2012-06-27 |
2017-04-12 |
International Aids Vaccine Initiative |
HIV-1 env glycoprotein variant
|
WO2014010231A1
(en)
|
2012-07-10 |
2014-01-16 |
Oncotherapy Science, Inc. |
Kif20a epitope peptides for th1 cells and vaccines containing the same
|
EP2872531A4
(en)
|
2012-07-10 |
2016-04-06 |
Oncotherapy Science Inc |
LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
|
MX362912B
(es)
|
2012-09-11 |
2019-02-22 |
Oncotherapy Science Inc |
Péptidos ube2t y vacunas que incluyen los mismos.
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Kntc2胜肽及含此胜肽之疫苗
|
EA034056B1
(ru)
|
2013-03-12 |
2019-12-23 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Усовершенствованные вакцины против вируса папилломы человека и способы их применения
|
EA034110B1
(ru)
|
2013-03-15 |
2019-12-27 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Противораковые вакцины и способы лечения с их применением
|
KR20210088754A
(ko)
|
2013-03-15 |
2021-07-14 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
구제역 바이러스 (fmdv) 공통 단백질, 그에 대한 코딩 서열 및 그로부터 제조된 백신
|
ES2886999T3
(es)
|
2013-03-27 |
2021-12-21 |
Immunovaccine Technologies Inc |
Procedimiento para mejorar la eficacia de una vacuna de survivina en el tratamiento de cáncer
|
US9428748B2
(en)
|
2013-06-17 |
2016-08-30 |
Hong Gao |
Method of expanding hematopoietic stem cells
|
KR20160037196A
(ko)
|
2013-07-31 |
2016-04-05 |
더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 |
종양 연관된 탄수화물 항원을 표적으로 하는 암을 치료하고 예방하기 위한 조성물과 방법
|
EP2848937A1
(en)
|
2013-09-05 |
2015-03-18 |
International Aids Vaccine Initiative |
Methods of identifying novel HIV-1 immunogens
|
CA2923129C
(en)
|
2013-09-08 |
2020-06-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP2873423B1
(en)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
SG11201700839SA
(en)
|
2014-08-04 |
2017-03-30 |
Oncotherapy Science Inc |
Cdca1-derived peptide and vaccine containing same
|
JP6754958B2
(ja)
|
2014-08-04 |
2020-09-16 |
オンコセラピー・サイエンス株式会社 |
Koc1由来ペプチドおよびそれを含むワクチン
|
CN106795204B
(zh)
|
2014-08-04 |
2021-09-28 |
肿瘤疗法科学股份有限公司 |
Urlc10衍生的肽和含有它们的疫苗
|
WO2016109880A1
(en)
|
2015-01-06 |
2016-07-14 |
Immunovaccine Technologies Inc. |
Lipid a mimics, methods of preparation, and uses thereof
|
BR112017017460A2
(pt)
|
2015-02-19 |
2018-04-10 |
Pfizer Inc. |
composições de neisseria meningitidis e métodos das mesmas
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
EP3072901A1
(en)
|
2015-03-23 |
2016-09-28 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
WO2016179034A2
(en)
|
2015-05-01 |
2016-11-10 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for stimulating immune response using potent immunostimulatory rna motifs
|
EP4276106A3
(en)
|
2015-05-13 |
2024-01-24 |
The United States of America as represented by the Secretary of the Department of Health and Human Services |
Methods and compositions for inducing an immune response using conserved element constructs
|
SG11201802881YA
(en)
|
2015-10-08 |
2018-05-30 |
Oncotherapy Science Inc |
Foxm1-derived peptide, and vaccine including same
|
CA3013718C
(en)
|
2016-02-05 |
2023-09-26 |
Jian Yan |
Cancer vaccines and methods of treatment using the same
|
CN110234658B
(zh)
|
2017-01-31 |
2024-03-12 |
辉瑞大药厂 |
脑膜炎奈瑟菌组合物及其使用方法
|
EP3723812A4
(en)
|
2017-12-13 |
2022-02-16 |
Inovio Pharmaceuticals, Inc. |
MUC16-TARGETING CANCER VACCINES AND THEIR USES
|
EP3737397B1
(en)
|
2017-12-13 |
2022-11-30 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting prame and uses thereof
|
AU2018383658B2
(en)
|
2017-12-13 |
2022-02-10 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting mesothelin and uses thereof
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
WO2020051766A1
(zh)
|
2018-09-11 |
2020-03-19 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
EP3889264A4
(en)
|
2018-11-30 |
2022-10-12 |
Tokushima University |
BREAST CANCER THERAPEUTIC WITH BIG3-PHB2 INTERACTION INHIBITING PEPTIDE FROM PHB2
|
KR102237349B1
(ko)
|
2019-10-23 |
2021-04-07 |
한국과학기술연구원 |
니코틴 중독 또는 금단 증상 예방 또는 치료용 약학 조성물
|
AU2022314055A1
(en)
|
2021-07-19 |
2024-02-08 |
New York University |
Adeno-associated viral vector compositions and methods of promoting muscle regeneration
|
WO2023121445A1
(en)
*
|
2021-12-22 |
2023-06-29 |
Sapreme Technologies B.V. |
Compositions comprising therapeutic nucleic acid and saponin for the treatment of muscle-wasting disorders
|